Advertisement

Topics

JLL Patheon Holdings, LLC Company Profile

00:47 EST 24th November 2017 | BioPortfolio


News Articles [302 Associated News Articles listed on BioPortfolio]

Thermo Fisher Completes Acquisition of Patheon

Adds Patheon’s leading CDMO capabilities to it portfolio

Patheon NV Strategy, SWOT and Corporate Finance Report [Report Updated: 30092017] Prices from USD $175

Patheon NV Strategy, SWOT and Corporate Finance ReportSummaryPatheon NV Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the ...

Thermo Fisher announces completion of $7.2B Patheon purchase

Thermo Fisher Scientific finalized the $7.2 billion acquisition of 95.3% in ordinary shares of Patheon, a contract developmen -More- 

Thermo Fisher pulls in funding as it preps for Patheon acquisition

Thermo Fisher Scientific has announced offerings of common stock after extending its tender offer to purchase Patheon.

Thermo completes acquisition of Patheon

Thermo Fisher Scientific has announced the completion of its acquisition of Patheon, contract development and manufacturing organisation (CDMO) for the pharma and biotech sectors, for approximately $7...

Patheon invests in key sites to support continued growth

Global provider of drug development and delivery solutions to the pharmaceutical sector, Patheon, has revealed it is anticipating to invest approximately $45 million at key sites worldwide to meet gro...

Patheon to spend $45m on manufacturing plants ahead of Thermo takeover

Patheon NV has announced it will spend $45m to expand and enhance its manufacturing network citing customer demand for more reliable, flexible and cost-efficient supply chains.

DSM Makes $1.7B in Thermo Fisher Acquisition of Patheon

NewsThermo Fisher has acquired all the shares of Patheon held by DSM for $35.00 per ordinary share in cash, resulting in a transaction payment to DSM of approximately $1.7 billion in cash.

PubMed Articles [7 Associated PubMed Articles listed on BioPortfolio]

Pig movements in France: Designing network models fitting the transmission route of pathogens.

Pathogen spread between farms results from interaction between the epidemiological characteristics of infectious agents, such as transmission route, and the contact structure between holdings. The obj...

Modelling virus coinfection to inform management of maize lethal necrosis in Kenya.

Maize lethal necrosis (MLN) has emerged as a serious threat to food security in sub-Saharan Africa. MLN is caused by coinfection with two viruses, maize chlorotic mottle virus (MCMV) and a potyvirus, ...

Impact of genetic variation on three dimensional structure and function of proteins.

The Protein Data Bank (PDB; http://wwpdb.org) was established in 1971 as the first open access digital data resource in biology with seven protein structures as its initial holdings. The global PDB ar...

Entomological Collections in the Age of Big Data.

With a million described species and more than half a billion preserved specimens, the large scale of insect collections is unequaled by those of any other group. Advances in genomics, collection digi...

Knowledge, attitudes, and practices of women farmers concerning tobacco agriculture in a municipality in Southern Brazil.

The study aimed to explore the knowledge, attitudes, and practices of women farmers working in tobacco production concerning the social, environmental, and health impacts of this economic activity. Fo...

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

Study of Pharmacokinetics and Preliminary Efficacy in Patients With Niemann-Pick C1

This research study is being conducted to find out whether Trappsol® Cyclo™, an experimental treatment for people with Niemann-Pick disease Type C1 (NPC-1) is safe at 3 different dose l...

Study of the Pharmacokinetics of Trappsol and Effects on Potential Biomarkers of Niemann-Pick C1 (NPC1)

This research study is being conducted to find out whether Trappsol® Cyclo™, an experimental treatment for people with Niemann Pick disease Type C (NPC-1) is safe at 2 different dose le...

Companies [416 Associated Companies listed on BioPortfolio]

Patheon Inc.

Patheon is a leading provider of contract development and commercial manufacturing (CDMO) services to the global pharmaceutical industry for a full array of solid and sterile dosa...

JLL Patheon Holdings, LLC

Patheon N.V.

Patheon is a leading global provider of pharmaceutical development and manufacturing services. With approximately 9,100 employees and contractors worldwide, Patheon provides a com...

Patheon

Patheon, based in Toronto, Canada, is a leading international provider of pharmaceutical contract manufacturing and development services. Established in 1974, Patheon has grown into a fully integrated...

Integra Holdings

Founded by Yissum, Integra Holdings is a unique venture fund, focusing on an exclusive selection of biotech companies with proprietary solutions and a competitive advantage in the...

More Information about "JLL Patheon Holdings, LLC" on BioPortfolio

We have published hundreds of JLL Patheon Holdings, LLC news stories on BioPortfolio along with dozens of JLL Patheon Holdings, LLC Clinical Trials and PubMed Articles about JLL Patheon Holdings, LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of JLL Patheon Holdings, LLC Companies in our database. You can also find out about relevant JLL Patheon Holdings, LLC Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record